Patents
Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210)
08/2012
08/21/2012US8247193 Method for producing α-L-aspartyl-L-phenylalanine-β-ester and method for producing α-L-aspartyl-L-phenylalanine-α-methyl ester
08/21/2012US8247192 Penicillin-G acylases
08/21/2012US8247189 Modified flavin adenine dinucleotide-dependent glucose dehydrogenase
08/21/2012US8247179 Processes for quantitative or qualitative detection of single-stranded nucleic acids
08/21/2012US8247173 Spinocerebellar ataxia type 8 and methods of detection
08/21/2012US8247169 SiRNA targeting diacylglycerol O-acyltransferase homolog 2 (DGAT2)
08/21/2012US8247167 HIV-1 latency model for high throughput screening
08/21/2012US8246958 Methods of inhibiting alpha-4-dependent interactions with VCAM-1 with anti-VLA-4 antibodies
08/21/2012US8246955 Substance specific to human PD-1
08/21/2012US8246953 Compositions and methods for use for antibodies against sclerostin
08/21/2012US8246945 Methods and reagents for decreasing clinical reaction to allergy
08/21/2012CA2633413C Antibodies against tumor-associated antigenic target (tat) polypeptides
08/21/2012CA2594178C Methods of production of modified proteins
08/21/2012CA2579798C Interleukin-15 antagonist peptide
08/21/2012CA2569108C Angiogenesis-inhibiting chimeric protein and the use
08/21/2012CA2560444C Tape stripping methods for analysis of skin disease and pathological skin state
08/21/2012CA2531526C Compositions and methods relating to multimeric and oligomeric soluble fragments of the tweak receptor
08/21/2012CA2529179C Recombinant adeno-associated virus vector for treatment of alzheimer disease
08/21/2012CA2485587C Muteins of placental growth factor type 1, preparation method and application thereof
08/21/2012CA2483848C Antibody against human insulin-like growth factor
08/21/2012CA2480717C Method for producing monoclonal antibodies
08/21/2012CA2478910C Methods and means for monitoring and modulating gene silencing
08/21/2012CA2472202C Method of constructing chimeric plant by heavy-ion beam irradiation
08/21/2012CA2428698C Methods of screening for ltrpc7 modulators
08/21/2012CA2428053C Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates
08/21/2012CA2424400C Adaptation sites of prrsv
08/21/2012CA2362830C Transmembrane serine protease overexpressed in ovarian carcinoma and uses thereof
08/21/2012CA2331884C Inducible pathogenesis-related plant promoters
08/21/2012CA2327529C Genes for desaturases to alter lipid profiles in corn
08/21/2012CA2210190C Method for modulating processes mediated by farnesoid activated receptors
08/18/2012CA2768801A1 Generation of virus-like particles and use as panfilovirus vaccine
08/16/2012WO2012109675A1 Aptamers to tissue factor pathway inhibitor and their use as bleeding disorder therapeutics
08/16/2012WO2012109667A1 Therapeutic compounds
08/16/2012WO2012109615A1 Purification systems and methods
08/16/2012WO2012109601A2 Methods and compositions for producing alkenes of various chain lengths
08/16/2012WO2012109578A2 Clostridium thermocellum strains for enhanced ethanol production and method of their use
08/16/2012WO2012109570A1 Viral vectors with modified transduction profiles and methods of making and using the same
08/16/2012WO2012109515A1 Synthetic insecticidal proteins active against corn rootworm
08/16/2012WO2012109470A2 Mutant luciferases
08/16/2012WO2012109395A1 Oligomeric compounds comprising bicyclic nucleotides and uses thereof
08/16/2012WO2012109296A1 Antisense oligonucleotides
08/16/2012WO2012109214A1 Targeted transduction of aav vectors
08/16/2012WO2012109208A2 Hematopoietic precursor cell production by programming
08/16/2012WO2012109199A1 Neural transfection reagents
08/16/2012WO2012109167A1 Immunogenic composition comprising alpha-hemolysin oligopeptides
08/16/2012WO2012109097A1 Methods for increasing plasmin activity and promoting plaque regression in the treatment of atherosclerosis
08/16/2012WO2012108845A1 A bacterial surrogate for testing of antimalarials: thya knockout and fola knockout bacteria for testing of inhibition of malarial dihydrofolate reductase-thymidylate synthase
08/16/2012WO2012108843A1 Treating cancer by inhibiting expression of olfm4, sp5, tobi, arjdia, fbni or hat1
08/16/2012WO2012108840A1 A novel expression cassette for efficient surface display of antigenic proteins
08/16/2012WO2012108782A1 Antibody that stops or slows tumour growth (variants)
08/16/2012WO2012108740A2 Mutant microorganism with enhanced sugar utilization and methods for preparing the same
08/16/2012WO2012108706A2 Kit for diagnosing tamiflu-sensitive and resistant novel influenza a (h1n1) simultaneously and diagnosis method using same
08/16/2012WO2012108675A2 Pna aptamer able to isolate a metal
08/16/2012WO2012108672A2 Reverse transcriptase having improved thermostability
08/16/2012WO2012108669A2 Uranyl ion specific dna aptamer
08/16/2012WO2012108630A2 Sbta gene derived from synechocystis sp. pcc6803 and use thereof
08/16/2012WO2012108548A1 TRANSFORMANT HAVING Gm1 GENE, GPCR GENE, AND CRMP2 GENE INTRODUCED THEREIN
08/16/2012WO2012108527A1 Predictive marker of progression to hepatocellular carcinoma
08/16/2012WO2012108518A1 Bacteriocin derived from lactobacillus rhamnosus
08/16/2012WO2012108499A1 Method for detecting nucleic acid
08/16/2012WO2012108493A1 Method for producing target substance by fermentation process
08/16/2012WO2012108471A1 Manufacturing method for nucleic acid extract
08/16/2012WO2012108444A1 Cardiomyopathy-specific pluripotent stem cell and use thereof
08/16/2012WO2012108424A1 Lectin presenting cell, lectin library, and screening method for lectin
08/16/2012WO2012108419A1 Composition that augments plant disease resistance and/or branching
08/16/2012WO2012108397A1 Novel lipid
08/16/2012WO2012108394A1 Method for screening substance relating to endoplasmic reticulum stress participating in onset of diabetes
08/16/2012WO2012108195A1 Method for producing virus vector for gene transfer
08/16/2012WO2012107932A1 B cell clonal immunotoxin and use thereof
08/16/2012WO2012107724A1 Mir-30 for use in the modulation of angiogenesis
08/16/2012WO2012107589A1 Methods and pharmaceutical compositions for the treatment and prevention of hcv infections
08/16/2012WO2012107531A1 B-type plexin antagonists and uses thereof
08/16/2012WO2012107417A1 Mutant interleukin-2 polypeptides
08/16/2012WO2012106824A1 Cellulase enzyme mixtures for depilling and uses thereof
08/16/2012WO2012106759A1 Modified plant defensins useful as anti-pathogenic agents
08/16/2012WO2012087017A3 Modified human tumor necrosis factor receptor-1 polypeptide or fragment thereof and method for preparing same
08/16/2012WO2012084996A3 Methods for identifying biologically active oligonucleotides capable of modulating the immune system
08/16/2012WO2012084993A3 Biologically active oligonucleotides capable of modulating the immune system i
08/16/2012WO2012082823A3 Formicidae (ant) control using double-stranded rna constructs
08/16/2012WO2012078949A3 Methods and compositions using small interfering rna (sirna) for nematode control in plants
08/16/2012WO2012071592A3 A humanized transgenic animal
08/16/2012WO2012071096A3 Arid1a and ppp2r1a mutations in cancer
08/16/2012WO2012068383A3 ncRNA AND USES THEREOF
08/16/2012WO2012068317A3 Methods for producing recombinant proteins
08/16/2012WO2012068236A3 Novel fungal oxidoreductases
08/16/2012WO2012065043A3 Classification of nucleic acid templates
08/16/2012WO2012061828A3 Neuronal specific targeting of caveolin expression to restore synaptic signaling and improve cognitive function in the neurodegenerative brain and motor function in spinal cord
08/16/2012WO2012061513A3 Soybean markers linked to scn resistance
08/16/2012WO2012058592A3 Non-antagonistic egfr-binding molecules and immunoconjugates thereof
08/16/2012WO2012051599A8 Modulation neural pathways
08/16/2012WO2012047679A8 Consensus antigen constructs and vaccines made therefrom, and methods of using same to treat malaria
08/16/2012WO2012047595A3 Maize cytoplasmic male sterility (cms) c-type restorer rf4 gene, molecular markers and their use
08/16/2012WO2012031079A3 L-malate production by metabolically engineered escherichia coli
08/16/2012WO2012027473A3 Immunogenic compositions comprising alphavirus vectored dengue virus e protein antigens
08/16/2012WO2012027374A3 Novel fungal carbohydrate hydrolases
08/16/2012WO2012012531A3 Compositions and methods featuring il-6 and il-21 antagonists
08/16/2012WO2011159928A3 Anti-dr4 agonist antibodies
08/16/2012WO2011149255A9 Modified rnase h and detection of nucleic acid amplification
08/16/2012WO2011126808A9 Pharmacologically induced transgene ablation system
08/16/2012WO2011091716A9 Epidermal growth factor receptor variant